Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07438743

An Evaluation of Epic EHR AI Outpatient Chart Summarization

This is a RCT of 284 outpatient physicians at a large academic health system, randomized 1:1 to an electronic health record (EHR) produced generative AI outpatient chart summarization tool or a usual-care control group. The 90 day study will observe the effects of the tool prior to system-wide roll out of the tool.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of California, Los Angeles

Los Angeles, California, 90095, United States

About this study

The primary aim of this study is to evaluate the impact of an EHR developed generative AI outpatient chart summarization tool on self-reported physician-task load score (PTL), comparing the tool to a control group. Exploratory outcomes include EHR-derived time metrics (Caboodle and Signal), Professional fulfillment Index (PFI), usability (SUS), provider satisfaction and productivity, and patient experience item results from CG-CAHPS. We will also evaluate whether AI literacy modifies adoption and effect of the tool using the short-form Meta AI Literacy Scale (MAILS). On an exploratory basis, we will also perform adjustments based on provider specialty, access to an ambient-listening AI scribe, panel complexity, provider age group, provider sex, and time-varying effects by month over the study period.

Enrolled participants are randomized to one of two groups. Randomization will be stratified by whether the participant has an active AI scribe license, and covariate-constrained randomization will be performed within strata to improve balance on baseline PTL (NASA-TLX-adapted score) and a modified baseline chart review time (Caboodle-derived). Due to the nature of the intervention, participants cannot be blinded to group assignment.

The primary purpose of the initiative is to improve quality, efficiency, and business operations at University of California, Los Angeles (UCLA) Health and will inform the operational implementation of the tool across all providers within the UCLA Health System. Nevertheless, the UCLA study team plans to rigorously examine and publish the impact of this intervention across the health system, which is why the study team pre-registered the initiative.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ambulatory care providers within the UCLA Health system including physicians and advanced practice providers (APPs), such as nurse practitioners and physician assistants with at least one half-day clinic session per week.
  • Providers complete baseline pre-survey

Exclusion criteria

  • Trainee providers (e.g., residents, medical students), and psychologists

Treatment and study plan

GenAI Chart Summarization

Other

Epic's generative AI chart summarization tool summarizes a subset of a patient's notes. Use of the tool is optional and intended solely to provide a summary for providers and does not provide clinical decision support. The system automatically selects recent notes or a provider can manually select specific notes of interest. The number of notes summarized is limited by the character constraints of the EHR, 24,000 English characters or 30 notes. The system uses AI to generate a short summary of relevant information. The summaries are meant to be used as a tool to aid providers and are not intended to be placed in clinical notes. The summaries created are currently not stored in the patient's chart.

Primary outcomes

  1. Change from Baseline Physician Task Load

    Time frame: Baseline and 90 days after initial exposure to the intervention

    Physician task load adapted from the NASA Task Load Index (TLX), a validated tool for assessing EHR-related cognitive task load in four sub-scales (mental demand, temporal demand, physical demand, and effort). This outcome is adapted to capture the task of pre-charting, defined for this study as the practice of reviewing patient information in the EHR before a patient visit to prepare for the encounter. Each sub-scale is rated from 0 (low) to 100 (high) and is aggregated to a 0-400 point scale. No patient level information will be collected for this outcome measure.

Secondary outcomes

  1. Change in Modified Total Chart Time Per Encounter

    Time frame: Baseline, after 60 days of exposure to the intervention, and after 90 days of exposure to the intervention.

    Using Caboodle, Epic's enterprise data warehouse, we will use a customized metric to measure clinician time spent reviewing the patient's chart. Based on internal validation where clinicians could access the chart summarization tool, the metric includes Caboodle Tier 1 activities corresponding to Clinical Review (all activities), Documentation limited to pre-charting activity only, and Other limited to Navigator-related activity, as well as the activity dedicated to the chart summarization tool. All note-writing, order entry, and encounter-signing activities are excluded. Time post checkout is also excluded. Change will be assessed relative to a 6-month retrospective baseline. No patient level information will be collected for this outcome measure.

  2. Change from Baseline Professional Fulfillment Index Score

    Time frame: Baseline and 90 days after initial exposure to the intervention

    The Professional Fulfillment Index (PFI) is a validated 16-item instrument that uses a 5-point Likert scale (0-4) to measure professional fulfillment, work exhaustion, and interpersonal disengagement. Burnout is reported based on combined results of the work exhaustion and interpersonal disengagement subscales. A higher score indicates greater level of exhaustion. No patient level information will be collected for this outcome measure.

  3. Change from Baseline Self-Reported Pre-Charting Effectiveness

    Time frame: Baseline and 90 days from initial exposure to the intervention

    Providers will answer questions regarding self-reported effectiveness and efficiency in pre-charting. The questions use a 5-point Likert scale to measure these metrics, with a higher score indicating greater self-reported efficiency and effectiveness.

  4. Provider Satisfaction Scores

    Time frame: 90 days after initial exposure to the intervention

    Self-reported satisfaction survey that includes physician reported effect of chart summarization tool on pre-charting efficiency and effectiveness, and other potential unintended consequences. No patient level information will be collected for this outcome.

  5. System Usability Scale

    Time frame: 90 days from initial exposure to the intervention

    The system usability scale (SUS) is a ten-item questionnaire that uses a 5-point Likert scale to measure different aspects of system usability. The total scale ranges from 0-100. A higher SUS score indicates higher usability.

  6. Safety Events

    Time frame: Over the 90 day period following after initial exposure to the intervention

    Clinician-reported safety of AI-generated chart summaries, including perceived frequency of clinically significant errors and occurrence of major safety events during the intervention period. No patient level information will be collected for this outcome.

  7. Qualitative Tool-Specific EHR Feedback

    Time frame: Over the 90 days following initial exposure to the intervention

    Aggregated real-time feedback submitted by clinicians through the EHR- native summarization interface during the intervention period, including ratings of accuracy, completeness, and hallucinations. No patient level information will be collected for this outcome.

  8. Change from Baseline Consumer Assessment of Healthcare Providers and Systems Clinician & Group Survey (CG-CAHPS) Metric

    Time frame: Baseline and 90 days after initial exposure to the intervention

    The Consumer Assessment of Healthcare Providers and Systems Clinician & Group Survey (CG-CAHPS) is a standardized patient feedback survey measuring experiences with providers. We will examine changes in the CG-CAHPS mean scores compared to 6 months prior to the intervention for the question "In the last 6 months, how often did this doctor seem to know the important information about your medical history".

  9. Change from Baseline Epic Signal (Activity) Metric: Time Outside Scheduled Hours

    Time frame: Baseline and 90 days after the initial exposure to the intervention

    We will examine change from a retrospective baseline 6 months prior to enrollment in Signal metrics including time outside scheduled hours per scheduled day. Using this data will determine how a provider's time is utilized in the EHR. No patient level information will be collected for this outcome measure.

  10. Clinician Relative Value Units (RVUs) per Week

    Time frame: 60 days after exposure to the intervention, and 90 days after exposure to the intervention

    Average relative value units (RVUs) per week during intervention months 2 and 3, adjusted for baseline (6-month pre-intervention period)

Sponsors and collaborators

Lead sponsor

University of California, Los Angeles

Other

Registry information

Official study title

Epic Generative Artificial Intelligence Chart Summarization Tool to Reduce Ambulatory Provider Cognitive Task Load: A Randomized Controlled Trial

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 27, 2026
Registry last updated
Mar 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.